People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

No significant difference seen between patients with colorectal cancer and color vision deficiency versus those without color vision deficiency.

People with color vision deficiency -- commonly known as color blindness -- may have a higher risk of mortality from bladder ...

People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...

On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

In a significant development for the field of oncology, ImmunityBio, Inc. (NASDAQ: IBRX) has recently announced positive results from its clinical trials focused on treating bladder cancer. This ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its evaluation of this information to potentially support a resubmission of the sBLA ...